42.1% Share of profit/loss from JVs/associaties (equity income) (24.7) 3.4 N.A. 8.6 N.A. Finance cost 458.2 113.0 305.5% 208.1 120.2% Reported Net Profit/Loss (253.7) (162.5) 56.1% (80.8) 213.9% GOP

fiscal year 2023 financial statements ended February 29, 2024 which were audited by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The operating performance is summarized as follows. Overview

result and submit our reviewed financial statements for Quarter 1/2018 Summary of the Company’s for the three-month period ended March 31, 2018 compared to that of the period ended March 31, 2017 as follow

Limited would like explanation about the Company’s financial performance and operation result and submit our reviewed financial statements for Quarter 1/2017 Summary of the Company’s for the three-month

Limited would like explanation about the Company’s financial performance and operation result and submit our reviewed financial statements for Quarter 2/2017 Summary of the Company’s for the period ended

Company Limited would like explanation about the Company’s financial performance and operation result and submit our reviewed financial statements for Quarter 3/2017 Summary of the Company’s for the period

Public Company Limited would like explanation about the Company’s financial performance and operation result and submit our reviewed financial statements for Quarter 3/2017 Summary of the Company’s for the

seller (Referring to the book value as of December 31, 2016 at Baht 150.89 per share) Summary of financial statements : Unit : Million Baht 2015 2016 Total assets 648.92 633.25 Total liabilities 185.02

foreign exchange hedging at Baht 3.3 million. Other income from sales of scraps, obsolete machine and equipment reported at Baht 1.8 million. Gross profit was down from 35.2% to 33.1% due to the increase in

Exchange of Thailand The Board of Directors’ Meeting of Ladprao General Hospital Public Company Limited (the “Company”), No.6/2018, held on August 10, 2018, has approved the financial statements of the